A commonly used chemotherapy drug in gastric cancer therapy, cisplatin, showed greater sensitivity in the high-CDK6-AS1 expression group than in the low-expression group (p = 0.024, Figure 8A). The gene discussed is CDK6; the disease is gastric cancer.